Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Astria Therapeutics (ATXS) Short-term Investments: 2018-2019

Historic Short-term Investments for Astria Therapeutics (ATXS) over the last 1 years, with Sep 2019 value amounting to $22.9 million.

  • Astria Therapeutics' Short-term Investments fell 2.20% to $22.9 million in Q3 2019 from the same period last year, while for Sep 2019 it was $22.9 million, marking a year-over-year decrease of 2.20%. This contributed to the annual value of $22.3 million for FY2018, which is N/A change from last year.
  • As of Q3 2019, Astria Therapeutics' Short-term Investments stood at $22.9 million, which was down 37.39% from $36.5 million recorded in Q2 2019.
  • Astria Therapeutics' 5-year Short-term Investments high stood at $40.0 million for Q1 2019, and its period low was $22.3 million during Q4 2018.
  • Over the past 2 years, Astria Therapeutics' median Short-term Investments value was $23.4 million (recorded in 2018), while the average stood at $29.0 million.
  • Data for Astria Therapeutics' Short-term Investments shows a maximum YoY dropped of 2.20% (in 2019) over the last 5 years.
  • Astria Therapeutics' Short-term Investments (Quarterly) stood at $22.3 million in 2018, then dropped by 2.20% to $22.9 million in 2019.
  • Its last three reported values are $22.9 million in Q3 2019, $36.5 million for Q2 2019, and $40.0 million during Q1 2019.